BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghouri YA, Tahan V, Shen B. Secondary causes of inflammatory bowel diseases. World J Gastroenterol 2020; 26(28): 3998-4017 [PMID: 32821067 DOI: 10.3748/wjg.v26.i28.3998]
URL: https://www.wjgnet.com/1007-9327/full/v26/i28/3998.htm
Number Citing Articles
1
Keiichi Tominaga, Takeshi Sugaya, Takanao Tanaka, Mimari Kanazawa, Makoto Iijima, Atsushi Irisawa. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel DiseasesFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.582291
2
Bo Shen, Gursimran S Kochhar, David T Rubin, Sunanda V Kane, Udayakumar Navaneethan, Charles N Bernstein, Raymond K Cross, Akira Sugita, Jason Schairer, Ravi P Kiran, Philip Fleshner, James T McCormick, André D’Hoore, Samir A Shah, Francis A Farraye, Revital Kariv, Xiuli Liu, Joel Rosh, Shannon Chang, Ellen Scherl, David A Schwartz, Paulo Gustavo Kotze, David H Bruining, Jessica Philpott, Bincy Abraham, Jonathan Segal, Rocio Sedano, Maia Kayal, Stuart Bentley-Hibbert, Dino Tarabar, Sandra El-Hachem, Priya Sehgal, Joseph A Picoraro, Séverine Vermeire, William J Sandborn, Mark S Silverberg, Darrell S Pardi. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch ConsortiumThe Lancet Gastroenterology & Hepatology 2022; 7(1): 69 doi: 10.1016/S2468-1253(21)00214-4
3
Cristina Bauset, Lluis Lis-Lopez, Sandra Coll, Laura Gisbert-Ferrándiz, Dulce C. Macias-Ceja, Marta Seco-Cervera, Francisco Navarro, Juan V. Esplugues, Sara Calatayud, Dolores Ortiz-Masia, Maria D. Barrachina, Jesús Cosín-Roger. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative ColitisBiomedicines 2022; 10(3): 532 doi: 10.3390/biomedicines10030532
4
Liqing Yang, Xi Zhong, Hao Yang, Qin Wu, Yuping Gong, Bo Wang. Pneumatosis cystoides intestinalis associated with etoposide in hematological malignancies: a case report and a literature reviewBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02219-8
5
Michele A. Serafini, Ana H. Paz, Natalia S. Nunes. Cholinergic immunomodulation in inflammatory bowel diseasesBrain, Behavior, & Immunity - Health 2022; 19: 100401 doi: 10.1016/j.bbih.2021.100401
6
Raffaele Borghini, Mariavittoria Vescovo, Carla Giordano, Giuseppe Donato, Antonio Picarelli. Onset of Suspected Ulcerative Colitis After Treatment With Tocilizumab in Patient With Celiac Disease and Juvenile Idiopathic ArthritisInflammatory Bowel Diseases 2021; 27(6): e76 doi: 10.1093/ibd/izab036
7
Rachele Del Sordo, Vassilios Lougaris, Gabrio Bassotti, Alessandro Armuzzi, Vincenzo Villanacci. Therapeutic agents affecting the immune system and drug-induced inflammatory bowel disease (IBD): A review on etiological and pathogenetic aspectsClinical Immunology 2022; 234: 108916 doi: 10.1016/j.clim.2021.108916
8
Luiz C. Di Stasi. Coumarin Derivatives in Inflammatory Bowel DiseaseMolecules 2021; 26(2): 422 doi: 10.3390/molecules26020422
9
Junfeng Zou, Chen Liu, Shu Jiang, Dawei Qian, Jinao Duan, Anthony R. Richardson. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative ColitisInfection and Immunity 2021; 89(9) doi: 10.1128/IAI.00014-21